Related Experiment Videos
Wegener's granulomatosis in the elderly
S S Krafcik1, R B Covin, J P Lynch
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0360, USA.
Chest
|February 1, 1996
Summary
Elderly patients with Wegener's granulomatosis (WG) show distinct symptoms, including less upper respiratory issues but more central nervous system (CNS) involvement. These older patients face a higher mortality risk, primarily from infections.
Area of Science:
- Rheumatology
- Internal Medicine
- Geriatrics
Background:
- Wegener's granulomatosis (WG) is a rare autoimmune disease affecting small to medium-sized blood vessels.
- Clinical presentation and outcomes in elderly patients with WG may differ from younger populations.
Purpose of the Study:
- To compare the clinical features and outcomes of Wegener's granulomatosis in elderly patients (≥60 years) versus younger patients (<60 years).
Main Methods:
- Retrospective cohort study conducted at a university medical center.
- Analysis of 33 elderly WG patients and 34 younger WG patients diagnosed over an 11-year period.
- Examination of clinical features, renal disease progression, mortality, and therapy complications.
Main Results:
- Elderly patients had less upper respiratory tract involvement and hemoptysis but more pulmonary infiltrates.
- Higher prevalence of renal insufficiency at diagnosis and significantly more central nervous system (CNS) involvement in elderly patients.
- Similar complication rates from therapy, but markedly higher mortality in elderly patients, mainly due to infection.
Conclusions:
- Elderly WG patients exhibit unique presentations, notably less upper respiratory symptoms and increased CNS involvement.
- The substantially higher mortality risk in elderly patients is linked to infections, not directly to therapy side effects.